(Q39975026)

16 September 2017

title

A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy (English)

1 reference

16 September 2017

main subject

angiogenesis inhibitor

1 reference

Qiming Sun

1

1 reference

16 September 2017

Qian Xu

2

1 reference

16 September 2017

Xiangbai Dong

3

1 reference

16 September 2017

Lin Cao

4

1 reference

16 September 2017

Xiaofeng Huang

5

1 reference

16 September 2017

Qingang Hu

6

1 reference

16 September 2017

Zi-Chun Hua

7

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

International Journal of Cancer

16 September 2017

published in

1 reference

16 September 2017

volume

123

1 reference

16 September 2017

issue

4

1 reference

16 September 2017

page(s)

942-950

1 reference

Angiogenesis in myelodysplastic syndromes

16 September 2017

cites work

1 reference

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

21 January 2018

1 reference

Urokinase-receptor (u-PAR): an essential player in multiple games of cancer: a review on its role in tumor progression, invasion, metastasis, proliferation/dormancy, clinical outcome and minimal residual disease

21 January 2018

1 reference

The role of plasminogen activators in the regulation of connective tissue metalloproteinases

21 January 2018

1 reference

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

21 January 2018

1 reference

Prevention of metastasis by inhibition of the urokinase receptor

21 January 2018

1 reference

Targeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTAT.

21 January 2018

1 reference

Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.

21 January 2018

1 reference

Overexpression of a hybrid gene consisting of the amino-terminal fragment of urokinase and carboxyl-terminal domain of bikunin suppresses invasion and migration of human ovarian cancer cells in vitro

21 January 2018

1 reference

Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism

21 January 2018

1 reference

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

21 January 2018

1 reference

Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth

21 January 2018

1 reference

Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice

21 January 2018

1 reference

Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures

21 January 2018

1 reference

An improved strategy for high-level production of human vasostatin120-180.

21 January 2018

1 reference

Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity

21 January 2018

1 reference

Nonmuscle myosin IIb is involved in the guidance of fibroblast migration

21 January 2018

1 reference

Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes

21 January 2018

1 reference

Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration

21 January 2018

1 reference

Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction

21 January 2018

1 reference

Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain

21 January 2018

1 reference

Albumin binding as a general strategy for improving the pharmacokinetics of proteins

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.23537

1 reference

release_wnmhbh3su5cf5nigrdpqebwibq

16 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wnmhbh3su5cf5nigrdpqebwibq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference